Skip to content

Clinical trial to examine the safety of early removal of chest tube after thoracic surgery

Clinical trial to examine the safety of early removal of chest tube after thoracic surgery - Clinical trial to examine the safety of early removal of chest tube after thoracic surgery

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044057
Enrollment
90
Registered
2021-04-27
Start date
2021-04-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases scheduled for thoracic surgery

Interventions

Chest tubes, which are commonly placed after thoracic surgery, are removed in the operating room.

Sponsors

Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who are scheduled to undergo the following surgical procedures at Saiseikai Fukuoka General Hospital. Surgery with resection of lung parenchyma (partial resection, segmentectomy, lobectomy) Surgery without resection of lung parenchyma (surgery for mediastinum, pleural disease, etc.) 2. Patients whose age at the time of surgery is 15 years or older. 3. Patients who received an explanation of this study and obtained written consent from the patient or his / her substitute. In the case of minors, patients who have obtained written consent from the patient and their parents. 4. Patients who can answer the questionnaire for pain evaluation.

Exclusion criteria

Exclusion criteria: 1. Patients scheduled for surgery with resection of the lung parenchyma show severe emphysematous changes and interstitial lung disease in the remaining lungs on preoperative imaging. 2. Patients who require combined resection and / or reconstruction of adjacent organs / structures such as the rib cage and diaphragm. 3. Patients who require continuous chest tube drainage after surgery, such as empyema. 4. Patients with high-risk factors for bleeding (patients with hemorrhagic disease, patients taking antithrombotic / anticoagulant) or with chest trauma that require observation of postoperative bleeding. 5. Other patients whose participation in this study was judged to be inappropriate by the surgeon.

Design outcomes

Primary

MeasureTime frame
Chest tube drain reinsertion rate

Secondary

MeasureTime frame
Postoperative hospital stay Post-operative complications, mortality within 30 days, in-hospital mortality Postoperative pain (NRS is described twice a day (9:00, 15:00) from the day after surgery to the day of discharge, and once a day (9:00) from the day of discharge to the day of the first outpatient visit. Evaluation of additional amount of analgesic and total oral dose of analgesic until the first outpatient day after surgery. Evaluation of NRS by surgical approach) Inpatient medical expenses Clinical findings (type of disease, surgical procedure, age, gender, height, weight, body mass index, smoking history, performance status, preoperative comorbidities), laboratory findings (blood count / biochemistry / coagulation test, respiratory function test), imaging findings (chest X-ray, computed tomography), intraoperative findings (surgical approach [video-assisted thoracoscopic surgery, thoracoscopic-assisted surgery, thoracotomy], intrathoracic adhesions, air leaks, methods of repairing air leaks)

Countries

Japan

Contacts

Public ContactNaoko Miura

Saiseikai Fukuoka General Hospital Department of surgery

nooir_nooka@yahoo.co.jp092-771-8151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026